October 3, 2008
338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein … (PR Newswire via Yahoo! Finance)
BioForm Medical, Inc. today announced that the pivotal clinical study of Polidocanol, conducted in Germany by BioForm Medical’s partner, Chemische Fabrik KREUSSLER & Co. GmbH , successfully met the study primary endpoint and has been submitted to FDA as part of a New Drug Application process. Full story…
Filed by Vein Doctor at 9:30 am under Vein Articles